Effect of a Mixture of Allium Extracts on LDL Cholesterol Levels Volunteers With Elevated LDL Cholesterol Levels
NCT04646382 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64
Last updated 2023-02-23
Summary
To evaluate the efficacy of daily consumption of a combination of concentrated extracts of garlic (Allium sativum L.) and onion (Allium cepa L.) on LDL cholesterol levels in healthy volunteers. Parameters related to metabolic syndrome, cardiovascular health and the immune system will also be analyzed.
Conditions
- Cardiovascular Health
Interventions
- DIETARY_SUPPLEMENT
-
Garlic and onion concentrate
Garlic extract concentrate (equivalent to 2 garlic cloves) and onion extract concentrate (equivalent to 1 onion).
- DIETARY_SUPPLEMENT
-
Control
Microcrystalline cellulose
Sponsors & Collaborators
-
DOMCA S.A.
lead INDUSTRY
Principal Investigators
-
Miguel Quesada, MD · Endocrinology and Nutrition Clinic of Dr. Miguel Quesada
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-02-01
- Primary Completion
- 2022-12-29
- Completion
- 2022-12-30
Countries
- Spain
Study Locations
More Related Trials
-
The Role of a Combination of Nutraceuticals in the Control of Cardiovascular Risk
NCT01293162 ·Status: COMPLETED
-
Trial of Supplementation With Aged Garlic Extract to Improve Endothelial Function in Patients With Metabolic Syndrome
NCT01168700 ·Status: UNKNOWN ·Phase: PHASE4
-
Cholesterol-Lowering Atherosclerosis Study (CLAS)
NCT00000599 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Oral Alpha-Cyclodextrin for Decreasing Serum Cholesterol
NCT01131299 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of a Dietary Supplement on Lipid Pattern and Liver Parameters in Hypercholesterolemia
NCT04485793 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol.
NCT00249938 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Arterin Cholesterol for Reduction of Lipid Levels
NCT04749784 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of a Probiotic on LDL-cholesterol Levels
NCT04029818 ·Status: COMPLETED ·Phase: PHASE1
-
Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)
NCT02597127 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants With Normal to Moderately High Low Density Lipoprotein-C (LDL-C) Levels (MK-0653A-259 AM1)
NCT01333436 ·Status: COMPLETED ·Phase: NA
-
Effect of Tredaptive on Serum Lipoproteins and Inflammatory Markers
NCT01054508 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Effects of Bioactive Compounds in Lipid Profile
NCT01562080 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects
NCT03609606 ·Status: COMPLETED ·Phase: PHASE1
-
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
NCT03273972 ·Status: COMPLETED ·Phase: NA
-
Dose Effect of Limicol on (LDL)-Cholesterol Levels
NCT01354340 ·Status: COMPLETED ·Phase: NA
-
A Phase 1 Study of an Investigational Drug, ALN-PCSSC, in Subjects With Elevated Low Density Lipoprotein Cholesterol (LDL-C)
NCT02314442 ·Status: COMPLETED ·Phase: PHASE1
-
Harvard Atherosclerosis Reversibility Project (HARP)
NCT00000461 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Niaspan on Cholesterol in Men
NCT00765284 ·Status: COMPLETED
-
Evaluation of the Effects of Two Dietary Supplement Formulations on the Lipid Profile in Mild Hypercholesterolemia
NCT06810466 ·Status: RECRUITING ·Phase: NA
-
the Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects in Adult Subjects With Elevated LDL-C
NCT06132360 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of LIMICOL®-NG on Plasma LDL-cholesterol Concentration in Subjects with Moderate Hypercholesterolemia
NCT06894251 ·Status: RECRUITING ·Phase: NA
-
Effects of Armolipid Plus on Cholesterol Levels and Endothelial Function
NCT00654459 ·Status: COMPLETED
-
Open-label Pharmacokinetic Study of Diazoxide Choline Coated vs. Uncoated Formulations
NCT00688857 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia
NCT05610280 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED)
NCT00769132 ·Status: COMPLETED ·Phase: PHASE1